Abstract
The involvement of microRNAs in human cancer is now well established. A few miRNAs function as oncogenes and many others display tumor suppressor activities. Several studies in the past few years have highlighted and reinforced a role for miR-203 as a tumor suppressor microRNA. This collection of in vitro studies give an initial and stimulating look into the many different means by which miR-203 can inhibit the various pathways involved in cell transformation and metastasis. Of special relevance is the ability of miR-203 to prevent proliferation of progenitor cells as well the epithelial-to-mesenchymal transition frequently associated with cancer progression and metastasis. Further more, the breadth of cancer types examined in these studies implicates miR-203 as a potential tumor suppressor gene whose reexpression or re-introduction into malignant cells could, by nature of its inherent pleiotropic effects as a miRNA, represent an important therapeutic tool used to combat a multitude of human cancers.
Keywords: Cell proliferation, microRNA, oncogenesis, progenitor cell, stemness, tumor suppression.
MicroRNA
Title:MicroRNA-203: Tumor Suppression and Beyond
Volume: 2 Issue: 2
Author(s): Carlos I. Michel and Marcos Malumbres
Affiliation:
Keywords: Cell proliferation, microRNA, oncogenesis, progenitor cell, stemness, tumor suppression.
Abstract: The involvement of microRNAs in human cancer is now well established. A few miRNAs function as oncogenes and many others display tumor suppressor activities. Several studies in the past few years have highlighted and reinforced a role for miR-203 as a tumor suppressor microRNA. This collection of in vitro studies give an initial and stimulating look into the many different means by which miR-203 can inhibit the various pathways involved in cell transformation and metastasis. Of special relevance is the ability of miR-203 to prevent proliferation of progenitor cells as well the epithelial-to-mesenchymal transition frequently associated with cancer progression and metastasis. Further more, the breadth of cancer types examined in these studies implicates miR-203 as a potential tumor suppressor gene whose reexpression or re-introduction into malignant cells could, by nature of its inherent pleiotropic effects as a miRNA, represent an important therapeutic tool used to combat a multitude of human cancers.
Export Options
About this article
Cite this article as:
Michel I. Carlos and Malumbres Marcos, MicroRNA-203: Tumor Suppression and Beyond, MicroRNA 2013; 2 (2) . https://dx.doi.org/10.2174/22115366113029990016
DOI https://dx.doi.org/10.2174/22115366113029990016 |
Print ISSN 2211-5366 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5374 |
Call for Papers in Thematic Issues
Modulatory Roles of Non-coding RNAs in cancer therapy
This thematic issue aims to elucidate the most recent research on ncRNAs in CRCs and discuss the importance and difficulties that may arise in applying this tool on a regular clinical basis.read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting the Nucleotide Metabolism Proteins of the NUDIX Family and SAMHD1 in Cancer
Current Medicinal Chemistry Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-Induced Cellular Apoptosis in Mouse Epidermal Cl41 Cells
Current Cancer Drug Targets The Metabolic Syndrome and HIV Infection
Current Pharmaceutical Design Bcl-2 Proteins: Targets and Tools for Chemosensitisation of Tumor Cells
Current Medicinal Chemistry - Anti-Cancer Agents Regulation of EMT by Notch Signaling Pathway in Tumor Progression
Current Cancer Drug Targets P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SAR & Future Perspective for Drug Design
Current Topics in Medicinal Chemistry Tumour Targeting with Systemically Administered Bacteria
Current Gene Therapy Oxidized Polysaccharides as Green and Sustainable Biomaterials
Current Organic Chemistry Carbohydrates: Potential Sweet Tools Against Cancer
Current Medicinal Chemistry The Role of the Osteoimmune Axis in the Inflammation of the Inner Auditory Ear and with Regard to the Putative Anticarcinogenetic Principle: Part 2
Inflammation & Allergy - Drug Targets (Discontinued) Impact of p53 arg72pro SNP on Breast Cancer Risk in North Indian Population
Current Genomics A Brief Evaluation of Tumor Imaging in Mice with 99mTc-glucarate Including a Comparison with 18F-FDG
Current Radiopharmaceuticals Modulation of Carbonic Anhydrase 9 (CA9) in Human Brain Cancer
Current Pharmaceutical Design The Ultrasonographic Diagnosis of Polycystic Ovary Syndrome
Current Medical Imaging The ALK Gene, An Attractive Target for Inhibitor Development
Current Topics in Medicinal Chemistry The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond
Current Molecular Imaging (Discontinued) Eosinophils in Cancer: Favourable or Unfavourable?
Current Medicinal Chemistry The Mechanisms and Quantification of the Selective Permeability in Transport Across Biological Barriers: the Example of Kyotorphin
Mini-Reviews in Medicinal Chemistry Antimicrobial Peptides in Oral Cancer
Current Pharmaceutical Design